Abiopharma

News list

Director Wei Xuan Kelly 🟢 acquired 1.0K shares (1 derivative) of NVE CORP /NEW/ (NVEC) at $129.43 Transaction Date: Aug 06, 2026 | Filing ID: 000007

Full text

News bot Aug. 10, 2026, 9:39 p.m.
🔍 Wei Xuan Kelly (Director)

Company: NVE CORP /NEW/ (NVEC)

Report Date: 2026-08-06
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,000
Detailed Transactions and Holdings:
- Acquired 1,000 shares of Non-Qualified Stock Option at $129.43 per share (Derivative)
  Date: 2026-08-06 | Code: A | Expires: 2036-08-06 | Exercise: 2026-08-06 | equity_swap_involved: 0 | shares_owned_after: 1,500.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Option granted automatically on Ms. Wei's reelection to NVE's Board of Directors.